Preview

Nephrology (Saint-Petersburg)

Advanced search

ROLE OF LOCAL INFECTIONS IN DEVELOPMENT OF UROLITHIASIS

https://doi.org/10.24884/1561-6274-2011-15-3-11-17

Abstract

Renal stone disease (uriolithiasis) is associated with salt metabolism disorder which promote formation of oxalate and mixed-type urinary concrements, e.g., hyperoxaluria, hypercalciuria, urinary citrate deficiency. Imbalanced salt-stabilizing functions of urinary proteins (in particular, Tamm-Horsfall protein, the major urinary protein with uroprotective and antimicrobial functions) are regarded as supplementary factors of occasional lythogenesis. Moreover, a sufficient role of local infections with urease-producing microorganisms (Proteusmirabilis, Corynebacterium urealyticum, Ureaplasma urealyticum etc.) is currently under consideration, as a reason of ammonium- and calcium phosphate stones ("infectious urolithiasis"). Invasive and cytotoxic properties of pathogenic bacterial strains lead to damage of urogenital mucosal surfaces, whereas urease production promotes urine alcalinization and formation of struvite stones. Meanwhile, some bacteria (e.g., Oxalobacter formigenes and some other intestinal microbes) are able to destroy oxalates, and therefore, are uroprotectants. Therefore, some microbial species being controlled by local immune mechanisms, have a sufficient significance both for development of urolithiasis, and for potential prevention of recurring.

About the Authors

A. B. CHUKHLOVIN
Санкт-Петербургский государственный медицинский университет им. И.П.Павлова
Russian Federation


Yu. V. EMANUEL
Санкт-Петербургский государственный медицинский университет им. И.П.Павлова
Russian Federation


O. V. NAPALKOVA
Санкт-Петербургский государственный медицинский университет им. И.П.Павлова
Russian Federation


S. V. LANDA
Санкт-Петербургский институт ядерной физики
Russian Federation


V. L. EMANUEL
Санкт-Петербургский государственный медицинский университет им. И.П.Павлова
Russian Federation


References

1. Эмануэль ВЛ. Пособие для семейного врача по лабораторным технологиям и интерпретации исследования мочи. «Триада», СПБ-Тверь, 2007; 128

2. Чухловин АБ. Факторы солевого баланса и возможная генетическая предрасположенность в развитии мочекаменной болезни. Клин Лаб Консилиум 2009; (1): 26-29

3. Coe FL, Parks JH. Pathogenesis and treatment of nephrolithiasis. In: Seldin D and Giebisch G, eds. The Kidney, Lippincott Williams and Wilkins, Philadelphia, 2000; 1841-1867

4. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 2003; 63: 255-265

5. Danpure CJ, Rumsby J. Molecular aetiology of primary hyperoxaluria and its implications for clinical management. Expert Rev Mol Med 2004; 6(1):1-16

6. Grover PK, Ryall RL, Marshall VR. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kidney Int 1992; 41:149-154

7. Lemann J, Jr, Worcester EM, Gray RW. Hypercalciuria and stones (review). Am J Kidney Dis 1991; 17:386-391

8. Curhan GC, Willett WC, Speizer FE, Stampfer MJ Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001; 59:2290-2298

9. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004; 89:4937-4943

10. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986; 30; 85-90

11. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate -a critical review. Urol Res 2005; 33(2):73-79

12. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 2008; 5(11):598-608

13. Miano R, Germani S, Vespasiani G. Stones and urinary tract infections. Urol Int 2007;79 [Suppl 1]:32-36

14. Musk DJ Jr, Hergenrother PJ. Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr Med Chem 2006; 13(18): 2163-2177

15. Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect 2008; 14(7):632-643

16. Raoult D, Drancourt M, Azza S et al. Nanobacteria are mineralo-fetuin complexes. PLoS Pathog 2008; 4(2): e41

17. Goldfarb DS. Microorganisms and calcium oxalate stone disease. Nephron Physiol 2004; 98(2): 48-54

18. Wang X, Lensdorf H, Ehrun I et al. Characteristics of biofilms from urinary tract catheters and presence of biofilm-related components in Escherichia coli. Curr Microbiol 2010; 60(6): 446-453.

19. Ong CL, Beatson SA, Totsika M et al. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol 2010; 10: 183

20. Stankowska D, Kwinkowski M, Kaca W. Quantification of Proteus mirabilis virulence factors and modulation by acylated homoserine lactones. J Microbiol Immunol Infect 2008; 41 (3): 243-253

21. Reyes L, Reinhard M, Brown MB. Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation. BMC Infect Dis 2009; 9:9

22. Zasloff M. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 2007; 18(11): 2810-2816

23. Soemann MD, Weichhart T, Zeyda M et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 2005; 115(2): 468-475

24. Song J, Bishop BL, Li G et al. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A 2009; 106(35):14966-14971

25. Abrink M, Larsson E, Gobl A, Hellman L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int 2000; 57(5):2004-2010

26. Tamm I, Horsfall F L. Characterisation and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 1950; 74: 108-114

27. Rosenfeld R, Bangio H, Gerwig G J et al. A lectin array-based methodology for the analysis of protein glycosylation. J Biochem Biophys Methods 2007; 70: 415-426

28. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 2003; 42(4): 658-676

29. Carvalho M, Mulinari RA, Nakagawa Y Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization. Braz J Med Biol Res 2002; 35: 1165-1172


Review

For citations:


CHUKHLOVIN A.B., EMANUEL Yu.V., NAPALKOVA O.V., LANDA S.V., EMANUEL V.L. ROLE OF LOCAL INFECTIONS IN DEVELOPMENT OF UROLITHIASIS. Nephrology (Saint-Petersburg). 2011;15(3):11-17. (In Russ.) https://doi.org/10.24884/1561-6274-2011-15-3-11-17

Views: 500


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)